Synthesis, biological activity and molecular modeling of a new series of condensed 1,2,4-triazoles. 2019

Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
Laboratoire de Chimie Organique Hétérocyclique, Centre de Recherche des Sciences des Médicaments, Pôle de Compétences Pharmacochimie, URAC 21, Faculté des Sciences, Université Mohammed V Rabat, Avenue Ibn Battouta, BP 10014 Rabat, Morocco; Organic Chemistry Department, Science Faculty, RUDN University Miklukho-Maklaya st. 6, 117198 Moscow, Russian Federation. Electronic address: yns.elbakri@gmail.com.

A ring transformation of 6-methyl-7H[1,2,4]triazolo [4,3-b][1,2,4] triazepine-8(9H)-ones (thiones) in the presence of acetic anhydride give rise to a new series of 17 condensed 1,2,4-triazole derivatives (1-17). Plausible mechanisms are proposed and show the formation of a beta fused β-lactam moiety. The compounds were tested for their (i) inhibitory potential on digestive enzymes (α-amylase and α-glucosidase), and (ii) antioxidant activity using radical scavenging (DPPH and ABTS radicals) and ferric reducing power assays. The compounds showed interesting and promising antidiabetic activities compared to the reference drug Acarbose. Molecular docking study has been carried out to determine the binding mode interactions between these derivatives and the targeted enzymes. The results showed the strength of intermolecular hydrogen bonding in ligand-receptor complexes as an important descriptor in rationalizing the observed inhibition results. Moreover, molecular dynamics simulations are also performed for the best protein-ligand complex to understand the stability of small molecule in a protein environment. To shed light on the antioxidant activity of the synthesized compounds and the mechanism involved in DPPH free radical, DFT calculations were performed at the B3P86/6-311++G(d,p) level using the polarizable continuum model. The effect of aprotic solvent on bond dissociation enthalpies (BDEs) is investigated by calculating and comparing BDEs of 1 in methanol and dimethylsulfoxide as solvents using PCM. The obtained results show that the mechanism of action depends on the basic skeleton and the presence of substituted functional groups in these derivatives. BDEs are found to be slightly influenced by the aprotic solvent of less than 0.01 kcal/mol compared with those obtained in methanol.

UI MeSH Term Description Entries
D007004 Hypoglycemic Agents Substances which lower blood glucose levels. Antidiabetic,Antidiabetic Agent,Antidiabetic Drug,Antidiabetics,Antihyperglycemic,Antihyperglycemic Agent,Hypoglycemic,Hypoglycemic Agent,Hypoglycemic Drug,Antidiabetic Agents,Antidiabetic Drugs,Antihyperglycemic Agents,Antihyperglycemics,Hypoglycemic Drugs,Hypoglycemic Effect,Hypoglycemic Effects,Hypoglycemics,Agent, Antidiabetic,Agent, Antihyperglycemic,Agent, Hypoglycemic,Agents, Antidiabetic,Agents, Antihyperglycemic,Agents, Hypoglycemic,Drug, Antidiabetic,Drug, Hypoglycemic,Drugs, Antidiabetic,Drugs, Hypoglycemic,Effect, Hypoglycemic,Effects, Hypoglycemic
D004121 Dimethyl Sulfoxide A highly polar organic liquid, that is used widely as a chemical solvent. Because of its ability to penetrate biological membranes, it is used as a vehicle for topical application of pharmaceuticals. It is also used to protect tissue during CRYOPRESERVATION. Dimethyl sulfoxide shows a range of pharmacological activity including analgesia and anti-inflammation. DMSO,Dimethyl Sulphoxide,Dimethylsulfoxide,Dimethylsulphinyl,Dimethylsulphoxide,Dimexide,Rheumabene,Rimso,Rimso 100,Rimso-50,Sclerosol,Sulfinylbis(methane),Rimso 50,Rimso50,Sulfoxide, Dimethyl,Sulphoxide, Dimethyl
D004353 Drug Evaluation, Preclinical Preclinical testing of drugs in experimental animals or in vitro for their biological and toxic effects and potential clinical applications. Drug Screening,Evaluation Studies, Drug, Pre-Clinical,Drug Evaluation Studies, Preclinical,Drug Evaluations, Preclinical,Evaluation Studies, Drug, Preclinical,Evaluation, Preclinical Drug,Evaluations, Preclinical Drug,Medicinal Plants Testing, Preclinical,Preclinical Drug Evaluation,Preclinical Drug Evaluations,Drug Screenings,Screening, Drug,Screenings, Drug
D005609 Free Radicals Highly reactive molecules with an unsatisfied electron valence pair. Free radicals are produced in both normal and pathological processes. Free radicals include reactive oxygen and nitrogen species (RONS). They are proven or suspected agents of tissue damage in a wide variety of circumstances including radiation, damage from environment chemicals, and aging. Natural and pharmacological prevention of free radical damage is being actively investigated. Free Radical
D000077318 Density Functional Theory A theory that is used to describe the electronic ground state properties of matter. It forms the basis of methods in obtaining a solution to the Schrodinger equation for a many-body system, and to investigate the structural, magnetic, and electronic properties of molecules and materials. Density Functional Calculations,Density Functional Computations,Density Functional Theory Calculations,Density Functional Theory Computations,Td-DFT,Td-DFT Calculations,Td-DFT Computations,Time-Dependent Density Functional Theory,Time-Dependent Density Functional Theory Calculations,Time-Dependent Density Functional Theory Computations,DFT Calculations,KS-DFT,Kohn-Sham Density Functional Theory,Calculation, Density Functional,Calculation, Td-DFT,Computation, Density Functional,Computation, Td-DFT,DFT Calculation,Density Functional Calculation,Density Functional Computation,Density Functional Theories,Functional Calculation, Density,Functional Calculations, Density,Functional Computation, Density,Kohn Sham Density Functional Theory,Td DFT Calculations,Td DFT Computations,Td-DFT Calculation,Td-DFT Computation,Time Dependent Density Functional Theory,Time Dependent Density Functional Theory Calculations,Time Dependent Density Functional Theory Computations
D000516 alpha-Amylases Enzymes that catalyze the endohydrolysis of 1,4-alpha-glycosidic linkages in STARCH; GLYCOGEN; and related POLYSACCHARIDES and OLIGOSACCHARIDES containing 3 or more 1,4-alpha-linked D-glucose units. Taka-Amylase A,alpha-Amylase,Alpha-Amylase Bayer,Maxilase,Mégamylase,alpha-1,4-D-Glucanglucanohydrolase,Alpha Amylase Bayer,AlphaAmylase Bayer,Taka Amylase A,TakaAmylase A,alpha 1,4 D Glucanglucanohydrolase,alpha Amylase,alpha Amylases
D000520 alpha-Glucosidases Enzymes that catalyze the exohydrolysis of 1,4-alpha-glucosidic linkages with release of alpha-glucose. Deficiency of alpha-1,4-glucosidase may cause GLYCOGEN STORAGE DISEASE TYPE II. Acid Maltase,Lysosomal alpha-Glucosidase,Maltase,Maltases,Maltase-Glucoamylase,Neutral Maltase,Neutral alpha-Glucosidase,alpha-Glucosidase,Lysosomal alpha Glucosidase,Maltase Glucoamylase,Neutral alpha Glucosidase,alpha Glucosidase,alpha Glucosidases,alpha-Glucosidase, Lysosomal,alpha-Glucosidase, Neutral
D000975 Antioxidants Naturally occurring or synthetic substances that inhibit or retard oxidation reactions. They counteract the damaging effects of oxidation in animal tissues. Anti-Oxidant,Antioxidant,Antioxidant Activity,Endogenous Antioxidant,Endogenous Antioxidants,Anti-Oxidant Effect,Anti-Oxidant Effects,Anti-Oxidants,Antioxidant Effect,Antioxidant Effects,Activity, Antioxidant,Anti Oxidant,Anti Oxidant Effect,Anti Oxidant Effects,Anti Oxidants,Antioxidant, Endogenous,Antioxidants, Endogenous
D012997 Solvents Liquids that dissolve other substances (solutes), generally solids, without any change in chemical composition, as, water containing sugar. (Grant & Hackh's Chemical Dictionary, 5th ed) Solvent
D013329 Structure-Activity Relationship The relationship between the chemical structure of a compound and its biological or pharmacological activity. Compounds are often classed together because they have structural characteristics in common including shape, size, stereochemical arrangement, and distribution of functional groups. Relationship, Structure-Activity,Relationships, Structure-Activity,Structure Activity Relationship,Structure-Activity Relationships

Related Publications

Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
January 1995, Acta poloniae pharmaceutica,
Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
February 2001, The Journal of pharmacy and pharmacology,
Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
January 2023, Advances and applications in bioinformatics and chemistry : AABC,
Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
September 2012, ACS medicinal chemistry letters,
Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
December 2016, Acta chimica Slovenica,
Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
November 2018, Bioorganic & medicinal chemistry letters,
Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
March 1978, Chemical & pharmaceutical bulletin,
Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
December 2022, Chemical biology & drug design,
Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
April 2020, Scientific reports,
Youness El Bakri, and Ilias Marmouzi, and Meryem El Jemli, and El Hassane Anouar, and Subramani Karthikeyan, and Abdallah Harmaoui, and My El Abbes Faouzi, and Joel T Mague, and El Mokhtar Essassi
March 2024, Heliyon,
Copied contents to your clipboard!